Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05259995 · ClinicalTrials.gov registry record · Phase 1
Sustained Acoustic Medicine Ultrasound Diathermy Clinical Performance
A Phase 1 study, sponsored by ZetrOZ.
- Completed
- Registry status
- Phase 1
- Development phase
- 54
- Enrollment target
NCT05259995 is a Phase 1 study that has completed, run by ZetrOZ. The registered enrollment target is 54 participants.
The verdict
NCT05259995, a Phase 1 study, has completed, sponsored by ZetrOZ.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to measure diathermy performance of Sustained Acoustic Medicine Devices with commercially available ultrasound gel coupling patches.
Interventions
- DEVICE Sustained Acoustic Medicine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2022-02-21 |
| Est. Completion | 2022-06-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05259995
The ClinicalTrials.gov registry entry for NCT05259995 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ZetrOZ, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sustained Acoustic Medicine is the first listed.
NCT05259995 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05259995 about?
NCT05259995 is a clinical study titled "Sustained Acoustic Medicine Ultrasound Diathermy Clinical Performance". The purpose of this study is to measure diathermy performance of Sustained Acoustic Medicine Devices with commercially available ultrasound gel coupling patches.
What is the current status of trial NCT05259995?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 54 participants. The study started on 2022-02-21. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT05259995?
The interventions under investigation include: Sustained Acoustic Medicine (DEVICE).
Who is sponsoring clinical trial NCT05259995?
This trial is sponsored by ZetrOZ, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.